These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 406995)

  • 1. Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventriculocisternal perfusion.
    Blasberg RG
    Cancer Treat Rep; 1977 Jul; 61(4):625-31. PubMed ID: 406995
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.
    Blasberg RG; Patlak CS; Shapiro WR
    Cancer Treat Rep; 1977 Jul; 61(4):633-41. PubMed ID: 406996
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.
    Blasberg RG; Patlak C; Fenstermacher JD
    J Pharmacol Exp Ther; 1975 Oct; 195(1):73-83. PubMed ID: 810575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of elimination of methotrexate from the cerebrospinal fluid space of monkeys after ventriculolumbar perfusion.
    Merker PC; Mehta BM; Cantor ML; Hutchison DJ
    Cancer Treat Rep; 1977 Jul; 61(4):603-11. PubMed ID: 406994
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of free and liposome-entrapped [3H]methotrexate in the central nervous system after intracerebroventricular injection in a primate.
    Kimelberg HK; Tracy TF; Watson RE; Kung D; Reiss FL; Bourke RS
    Cancer Res; 1978 Mar; 38(3):706-12. PubMed ID: 414833
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and metabolism of cytosine arabinoside in the central nervous system.
    Spector R
    J Pharmacol Exp Ther; 1982 Jul; 222(1):1-6. PubMed ID: 7086691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain extracellular space in developing normal and hydrocephalic kittens using ventriculocisternal perfusion.
    Shaywitz BA; Escriva A
    Neurology; 1970 Apr; 20(4):394-5. PubMed ID: 5535028
    [No Abstract]   [Full Text] [Related]  

  • 8. A primate model for study of methotrexate pharmacokinetics in the central nervous system.
    Poplack DG; Bleyer WA; Wood JH; Kostolich M; Savitch JL; Ommaya AK
    Cancer Res; 1977 Jul; 37(7 Pt 1):1982-5. PubMed ID: 405092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of [3H]cytosine arabinoside and its products in mice, dogs, and monkeys and effect of tetrahydrouridine.
    Dareer SM; Mulligan LT; White V; Tillery K; Mellett LB; Hill DL
    Cancer Treat Rep; 1977; 61(3):395-407. PubMed ID: 406044
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental approaches to the treatment of CNS leukemia.
    Poplack DG; Bleyer WA; Pizzo PA
    Am J Pediatr Hematol Oncol; 1979; 1(2):141-9. PubMed ID: 120681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
    Fujimoto T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct administration of methotrexate into the central nervous system of primates. Part 2: Distribution of 3H methotrexate after intrathecal lumbar injection.
    Yen J; Reiss FL; Kimelberg HK; Bourke RS
    J Neurosurg; 1978 Jun; 48(6):895-902. PubMed ID: 96229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuromeningeal localizations in acute leukemia and non-Hodgkin's lymphoma. Protocol combining BCNU-cytosine arabinoside].
    Donadio D; Navarro M; Izarn P
    Ann Med Interne (Paris); 1987; 138(2):143. PubMed ID: 3579096
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of carotid and venous injection of antitumor agent BCNU.
    Oldendorf WH
    Trans Am Neurol Assoc; 1975; 100():225-6. PubMed ID: 1226621
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct administration of methotrexate into the central nervous system of primates. Part 1: Distribution and degradation of methotrexate in nervous and systemic tissue after intraventricular injection.
    Kimelberg HK; Kung D; Watson RE; Reiss FL; Biddlecome SM; Bourke RS
    J Neurosurg; 1978 Jun; 48(6):883-94. PubMed ID: 96228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracarotid BCNU (NSC-409962): a toxicity study in six rhesus monkeys.
    Crafts DC; Levin VA; Nielsen S
    Cancer Treat Rep; 1976 May; 60(5):541-5. PubMed ID: 825222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.
    Dedrick RL; Myers CE; Bungay PM; DeVita VT
    Cancer Treat Rep; 1978 Jan; 62(1):1-11. PubMed ID: 626987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain inulin space in developing kittens using ventriculocisternal perfusion.
    Shaywitz BA
    Neurology; 1972 Mar; 22(3):238-45. PubMed ID: 5066920
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkey.
    Levin VA; Kabra PM; Freeman-Dove MA
    J Neurosurg; 1978 Apr; 48(4):587-93. PubMed ID: 416182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probenecid inhibition of methotrexate-cerebrospinal fluid pharmacokinetics in dogs.
    Ramu A; Fusner JE; Blaschke T; Glaubiger DL
    Cancer Treat Rep; 1978 Oct; 62(10):1465-70. PubMed ID: 581360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.